Advancing COVID-19 Research with the National Cancer Institute
Background of the CRWDi project While the COVID-19 pandemic is behind us, the virus remains a...
How the FDA is using real-world evidence in safety and approval decisions
Regulatory decision-making depends on evidence that reflects how medical products perform in real-world use, not only in controlled trials. For more than a decade, the Food and Drug Administration has relied on real-world data and real-world...
A guide to optimizing real-world data: Electronic medical records
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
Beyond the numbers: indirect ways to assess patient matching accuracy metrics
Part 4: Indirect and qualitative metrics for matching accuracy [Part 4] of Matching Accuracy...
Unlock better outcomes with real-world closed claims data from taXonomy
As high-value therapies become the new norm,life sciences teams need closed claims data that...
The biomarker advantage
HealthVerity COO Andrew Goldberg recently sat down with Quest Diagnostics’ Director, Health...
Open claims vs. closed payer claims: What’s the difference?
Open claims and closed payer claims data are essential for understanding the status and activities...
Manageable medical device monitoring with real-world data
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Mastering precision, not indecision in real-world data
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Enhancing go-to-market strategies with real-world data
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
Extending value long after the clinical trial with real-world data
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...